B10 – Quality Risk Management: Navigating the risks associated with imported medicines

Navigating the risks associated with imported medicines – with a considerable amount of manufacturing now completed overseas a thorough understanding of the risks and control associated with importing medicines is required. The session will examine how to identify and address key risks, what are some of the biggest hurdles and what tools are available to help us identify and control the risks which are identified

 

Chairperson: Helen Atkinson, ISPE Director / SeerPharma Pty Ltd